The presence of MUC1-ST TAMs in primary breast cancers, a MUC1-ST TAM signature being associated with poor prognosis and its phenotype contributing to systemic features of cancer, suggest that approaches based on targeting TAMs should include this subtype. The gene discussed is MUC1; the disease is breast cancer.